[1]
M. A. S. Al-Naseri, A. H. Ad’hiah, and E. D. Salman, “Predictive Significance of Interleukins 17A and 33 in Risk of Relapsing–Remitting Multiple Sclerosis”, Baghdad Sci.J, vol. 19, no. 6, p. 1191, Dec. 2022.